0001127602-23-030189.txt : 20231220 0001127602-23-030189.hdr.sgml : 20231220 20231220164230 ACCESSION NUMBER: 0001127602-23-030189 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231219 FILED AS OF DATE: 20231220 DATE AS OF CHANGE: 20231220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Thackray Helen M. CENTRAL INDEX KEY: 0001589725 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 231501810 MAIL ADDRESS: STREET 1: C/O GLYCOMIMETICS, INC. STREET 2: 401 PROFESSIONAL DRIVE, SUITE 250 CITY: GAITHERSBURG STATE: MD ZIP: 20879 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2023-12-19 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001589725 Thackray Helen M. 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 1 Chief R&D Officer 0 Common Stock 2023-12-19 4 F 0 5580 6.05 D 249664 D Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person. /s/ Alane P. Barnes, by power of attorney 2023-12-20